Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,162 INR | +1.89% | +2.69% | +6.06% |
May. 03 | Astec Lifesciences' CFO Resigns | MT |
May. 02 | Astec LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Sales 2024 | 4.58B 55.08M | Sales 2025 * | 6.76B 81.21M | Capitalization | 22.36B 269M |
---|---|---|---|---|---|
Net income 2024 | -469M -5.64M | Net income 2025 * | 579M 6.96M | EV / Sales 2024 | 4.57 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.31 x |
P/E ratio 2024 |
-44.6
x | P/E ratio 2025 * |
38.6
x | Employees | 551 |
Yield 2024 * |
-
| Yield 2025 * |
0.09% | Free-Float | 29.63% |
1 day | +1.89% | ||
1 week | +2.69% | ||
Current month | -9.56% | ||
1 month | -8.16% | ||
3 months | +28.03% | ||
6 months | -7.33% | ||
Current year | +6.06% |
Managers | Title | Age | Since |
---|---|---|---|
Anurag Roy
CEO | Chief Executive Officer | 50 | 21-07-27 |
Founder | 69 | 94-01-24 | |
Compliance Officer | - | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 15-10-11 | |
Director/Board Member | - | 22-07-24 | |
Director/Board Member | 59 | 15-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 1,162 | +1.89% | 22 302 |
24-05-22 | 1,140 | -0.43% | 21,915 |
24-05-21 | 1,145 | -1.96% | 26,187 |
24-05-18 | 1,168 | -1.07% | 7,502 |
24-05-17 | 1,181 | +4.36% | 46,931 |
Delayed Quote NSE India S.E., May 23, 2024 at 07:40 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.06% | 268M | |
+18.91% | 39.71B | |
-.--% | 11.39B | |
+0.90% | 7.94B | |
+4.24% | 6.74B | |
-1.16% | 6.07B | |
+0.27% | 6.03B | |
+30.96% | 5.18B | |
-14.04% | 5.43B | |
-13.13% | 4.65B |
- Stock Market
- Equities
- ASTEC Stock